Leqembi (lecanemab-irmb) - Biogen, Eisai
Evaluation, Prediction and Health Economic Analysis of Lecanemab Efficacy Based on Multimodal Digital Behavior and Blood Biomarkers: A Prospective Observational Cohort Study (ChiCTR) - Oct 16, 2026 - P=N/A | N=60 | Not yet recruiting | Sponsor: The first hospital of Shanxi Medical University; The first hospital of Shanxi Medical University 
New trial • Alzheimer's Disease • CNS Disorders
https://www.chictr.org.cn/showproj.html?proj=341077
 
Oct 16, 2026
 
Prev Next